← SynDRA
MIRIDESAP
SynDRA canonical compound SYN0001490 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
|---|
| Primary target(s) | APCS |
|---|
| Mechanism of action | amyloid protein inhibitor |
|---|
All known targets
Mechanisms of action (all sources)
- APCS CROSS-LINKING AGENT
- Serum amyloid P-component cross-linking agent
- amyloid protein inhibitor
- APCS MODULATOR
Cross-references
Synonyms
- CPHPC
- GSK2315698
- GSK-2315698
- RO-638695
- Ro 63-8695
- Amyloid beta inhibitor
- SAP binding inhibitor, Roche
- Serum amyloid P binding inhibitor, Roche
- Ro-63-8695
- GSK-2315698A
- Serum amyloid P depleter (iv, amyloidosis), GlaxoSmithKline
- Cphpc
- 1,1'-hexanedioyldi-D-proline
- WO97N24A47
- miridesapum
- RefChem:818906
- DTXCID6099487
- Miridesap [USAN]
- MFCD09970762
- (2R,2'R)-1,1'-Adipoylbis(pyrrolidine-2-carboxylic acid)
- 1,1'-(1,6-Dioxo-1,6-hexanediyl)bis-D-proline
- D-PROLINE, 1,1'-(1,6-DIOXO-1,6-HEXANEDIYL)BIS
- CPOHPC acid
- (2'R)-adipoyldi-D-proline
- UNII-WO97N24A47
- 4avt
- CPHPC(Miridesap)
- GHE
- CPHPC(Miridesap)?
- MIRIDESAP [INN]
- Miridesap (USAN/INN)
- MIRIDESAP [WHO-DD]
- GTPL8256
- orb1299946
- SCHEMBL1537496
- HZLAWYIBLZNRFZ-VXGBXAGGSA-N
- GLXC-15410
- EX-A14710
- AKOS030528069
Look up MIRIDESAP in the interactive SynDRA portal →